Science Explorer Back to mapMap
Discussion
Researcher · EyePoint Pharmaceuticals (United States) · United States

Dario A. Paggiarino

Dario A. Paggiarino publishes mostly in Ophthalmology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Retinal Diseases and Treatments, Ocular Diseases and Behçet’s Syndrome and Glaucoma and retinal disorders.

ORCID 0000-0002-8584-9833 OpenAlex
World rank
#2,377,899
of 7,710,434 ranked researchers
Rank in United States
#706,250
of 1,627,098
Works
26
Citations
834
Citations per work
32.1
h-index
11
i10-index 11Top 45% in Ophthalmology
Dario A. Paggiarino

What does Dario A. Paggiarino research?

Dario A. Paggiarino's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 16 works · 61.6% of their workMedicine: 16 works · 61.6% of their workOphthalmology: 10 works · 39.7% of their workPulmonary and Respiratory Medicine: 2 works · 9.6% of their workPhysiology: 1 works · 4.1% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 4.1% of their workSurgery: 1 works · 4.1% of their workEverything else: 7 works · 27.4% of their workLife Sciences: 3 works · 11.0% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 11.0% of their workMolecular Biology: 3 works · 11.0% of their workTHEIR WORKDario A.Paggiarino26works
Life Sciences11%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1661.6%
  2. Everything else727.4%
    1. Biochemistry, Genetics and Molecular Biology311.0%
  1. 1Ophthalmology40% of their works
  2. 2Molecular Biology11% of their works
  3. 3Pulmonary and Respiratory Medicine10% of their works
  4. 4Physiology4% of their works
  5. 5Surgery4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Dario A. Paggiarino's research?

The keywords of their largest research topics: Epidemiology, Macular Degeneration, Optical Coherence Tomography, Glaucoma, Behçet's Disease, Diabetic Retinopathy, Retinal Pigment Epithelium and Uveitis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Epidemiology102 topics
  2. Macular Degeneration102 topics
  3. Optical Coherence Tomography102 topics
  4. Glaucoma92 topics
  5. Behçet's Disease81 topic
  6. Diabetic Retinopathy81 topic
  7. Retinal Pigment Epithelium81 topic
  8. Uveitis81 topic
  9. Intraocular Pressure61 topic
  10. Optic Nerve61 topic
  11. COVID-1941 topic
  12. Ocular Findings41 topic
  13. Femtosecond Laser31 topic
  14. Intraocular Lens Implantation31 topic
  15. Gene Therapy21 topic
  16. Myopia21 topic
  17. Retinitis Pigmentosa21 topic
  18. Sphingolipids21 topic
  19. Sphingosine-1-Phosphate21 topic
  20. Visual Impairment21 topic

Where does Dario A. Paggiarino work?

Dario A. Paggiarino's main affiliation in the publication record is EyePoint Pharmaceuticals (United States), United States.

How many publications and citations does Dario A. Paggiarino have?

OpenAlex counts 26 works and 834 citations for Dario A. Paggiarino, an h-index of 11, ranking #2,377,899 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dario A. Paggiarino. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.